Rise Advisors LLC Sells 478 Shares of The Procter & Gamble Company (NYSE:PG)

Rise Advisors LLC reduced its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 22.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,655 shares of the company’s stock after selling 478 shares during the period. Rise Advisors LLC’s holdings in Procter & Gamble were worth $278,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Concurrent Investment Advisors LLC lifted its position in shares of Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after buying an additional 4,035 shares during the period. Copley Financial Group Inc. acquired a new position in Procter & Gamble during the third quarter worth $668,000. Fortem Financial Group LLC bought a new position in shares of Procter & Gamble during the fourth quarter valued at $569,000. Synovus Financial Corp grew its holdings in shares of Procter & Gamble by 3.4% in the 3rd quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock worth $32,065,000 after purchasing an additional 6,077 shares during the last quarter. Finally, Nordea Investment Management AB increased its position in shares of Procter & Gamble by 7.5% during the 4th quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock worth $484,583,000 after purchasing an additional 201,695 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Up 0.4 %

PG traded up $0.70 during mid-day trading on Tuesday, hitting $161.30. The stock had a trading volume of 4,063,602 shares, compared to its average volume of 5,820,512. The stock’s fifty day simple moving average is $170.03 and its 200-day simple moving average is $169.80. The firm has a market capitalization of $379.87 billion, a price-to-earnings ratio of 27.81, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The Procter & Gamble Company has a 1-year low of $146.28 and a 1-year high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.

Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period in the previous year, the company posted $1.83 earnings per share. The company’s revenue for the quarter was down .6% on a year-over-year basis. As a group, research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Insider Activity

In related news, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the transaction, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R. Alexandra Keith sold 1,992 shares of Procter & Gamble stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares in the company, valued at $2,343,110. This represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 75,439 shares of company stock worth $13,317,460 over the last quarter. 0.18% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on PG. Evercore ISI upped their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a report on Monday, September 30th. Morgan Stanley boosted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Finally, Piper Sandler assumed coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price objective on the stock. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $179.75.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.